- Ongoing, recruitingTherapeutic use (Phase IV)
Treating socket discharge and discomfort: randomized test of vitamin A ointment, low-dose steroids and artificial tears
This study looks at different ways to help people who have a sore or watery eye from wearing an artificial eye. It compares vitamin A ointment, a mild steroid, and regular eye drops to see which works best to reduce discomfort and discharge.
For: Chronic mucopurulent discharge and/or discomfort of the ocular prosthesis socketNetherlands - Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A randomized, open-label, single dose, cross-over bioavailability study evaluating the drug-drug interaction between Tritace 10, 10 mg, tablets and Tertensif SR 1.5 mg prolonged-release film-coated tablets when co-administered versus the administration of each product alone in two cohorts of healthy volunteers under fasting conditions. Sponsor's Study No.: RAM-IND-DDI-05-23
This study looks at how two common blood pressure medicines, Tritace 10 and Tertensif SR, act in the body when taken together compared to taking them alone. It's for healthy volunteers to see if one medicine changes how the other works.
For: NA - study in healthy subjectsCzechia - Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
Safety and Efficacy of a Unilateral Subretinal Administration of HORA PDE6B in Patients with Retinitis Pigmentosa Harbouring Mutations in the PDE6B Gene Leading to a Defect in PDE6ß Expression
This study is testing a new gene therapy for people with retinitis pigmentosa caused by a specific faulty gene. It's looking at how safe the treatment is and if it helps improve vision. Researchers are giving the treatment into one eye.
For: retinitis pigmentosaFrance